Immunologic Effector Cell Of Targeted Cld18A2, And Preparation Method And Use Thereof

Patent No. EP3170842 (titled "Immunologic Effector Cell Of Targeted Cld18A2, And Preparation Method And Use Thereof") was filed by Cafa Therapeutics on Jul 15, 2015. The application was issued on Sep 4, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BIONTECH CELL & GENE THERAPIESJun 4, 2020WILK

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3170842

CAFA THERAPEUTICS
Application Number
EP15821331A
Filing Date
Jul 15, 2015
Status
Revoked
Apr 27, 2024
Publication Date
Sep 4, 2019